Claim · model-written summary
1% or 2% MON extract had antibacterial properties toward Aggregatibacter actinomycetemcomitans at 25% and 12.5%, with significant differences.
- Taxon
- Moringa oleifera
Moringa oleiferat0 - Treatment
- 1% or 2% of MON extracte4
- Interactor
- Aggregatibacter actinomycetemcomitansAggregatibacter actinomycetemcomitanse5pathogen
- Outcome
- antibacterial propertiese4
- Value
- 25% and 12.5%e4
Not reportedDirection
Verbatim
t0“Moringa oleifera nanosuspension”
e4“1% or 2% of MON extract has antibacterial properties toward Aa, Pg, Pi, and Fn at concentrations of 25% and 12.5%, with significant differences”
e5“Prevotella intermedia (Pi), Porphyromonas gingivalis (Pg), Aggregatibacter actinomycetemcomitans (Aa), and Fusobacterium nucleatum (Fn) were tested for antibacterial activity of MON extract”
Title
Alexander Patera Nugraha; Ari Triwardhani; Ratri Maya Sitalaksmi; et al. Journal of Oral Biology and Craniofacial Research 2023. doi:10.1016/j.jobcr.2023.09.004
Other claims from this paper (8)
- Intervention effect MON extract had lower antioxidant capacity than vitamin C.
- Observation Flavonoids, saponins and quinones were found in MON extract.
- Observation Alkaloids, tannins and terpenoids were found in MON extract.
- Observation Steroids were found in MON extract.
- Observation 1% or 2% MON extract had antibacterial properties toward Porphyromonas gingivalis at 25% and 12.5%, with significant differences.
- Observation 1% or 2% MON extract had antibacterial properties toward Prevotella intermedia at 25% and 12.5%, with significant differences.
- Observation 1% or 2% MON extract had antibacterial properties toward Fusobacterium nucleatum at 25% and 12.5%, with significant differences.
- Observation MON extract has potential antioxidant activity.